{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:55:12Z","timestamp":1755795312802,"version":"3.44.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,17]]},"DOI":"10.7759\/cureus.90318","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T18:52:32Z","timestamp":1755456752000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti-Gamma-Aminobutyric Acid B (GABA-B) Receptor Encephalitis: A Case Series Analyzing Treatment Modalities and Cancer Screening Recommendations"],"prefix":"10.7759","author":[{"given":"Sebastian","family":"Garza Hernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayden","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binod","family":"Wagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nooshin","family":"Kiani Nia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster E","year":"2010","unstructured":"Lancaster E, Lai M, Peng X, et al.. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010, 9:67-76. 10.1016\/S1474-4422(09)70324-2","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00403","article-title":"Clinical characteristics of anti-GABA-B receptor encephalitis","volume":"11","author":"Zhu F","year":"2020","unstructured":"Zhu F, Shan W, Lv R, Li Z, Wang Q. Clinical characteristics of anti-GABA-B receptor encephalitis. Front Neurol. 2020, 11:403. 10.3389\/fneur.2020.00403","journal-title":"Front Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2018.0005","article-title":"A systematic review of gamma-aminobutyric acid receptor type B autoimmunity","volume":"53","author":"McKay JH","year":"2019","unstructured":"McKay JH, Dimberg EL, Lopez Chiriboga AS. A systematic review of gamma-aminobutyric acid receptor type B autoimmunity. Neurol Neurochir Pol. 2019, 53:1-7. 10.5603\/PJNNS.a2018.0005","journal-title":"Neurol Neurochir Pol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01030","article-title":"Encephalitis with antibodies against the GABA(B) receptor: high mortality and risk factors","volume":"10","author":"Lin J","year":"2019","unstructured":"Lin J, Li C, Li A, et al.. Encephalitis with antibodies against the GABA(B) receptor: high mortality and risk factors. Front Neurol. 2019, 10:1030. 10.3389\/fneur.2019.01030","journal-title":"Front Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz094","article-title":"The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies","volume":"142","author":"van Coevorden-Hameete MH","year":"2019","unstructured":"van Coevorden-Hameete MH, de Bruijn MA, de Graaff E, et al.. The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies. Brain. 2019, 142:1631-43. 10.1093\/brain\/awz094","journal-title":"Brain"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.168989","article-title":"Limbic encephalitis associated with anti-\u03b3-aminobutyric acid B receptor antibodies: a case series from China","volume":"128","author":"Guan HZ","year":"2015","unstructured":"Guan HZ, Ren HT, Yang XZ, et al.. Limbic encephalitis associated with anti-\u03b3-aminobutyric acid B receptor antibodies: a case series from China. Chin Med J (Engl). 2015, 128:3023-8. 10.4103\/0366-6999.168989","journal-title":"Chin Med J (Engl)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1756285617722347","article-title":"Treatment strategies for autoimmune encephalitis","volume":"11","author":"Shin YW","year":"2018","unstructured":"Shin YW, Lee ST, Park KI, Jung KH, Jung KY, Lee SK, Chu K. Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord. 2018, 11:1756285617722347. 10.1177\/1756285617722347","journal-title":"Ther Adv Neurol Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ibra.12017","article-title":"Research progress of anti-\u03b3-aminobutyric acid B receptor encephalitis and a case report of paraneoplastic associated encephalitis and treatment analysis","volume":"8","author":"Lv YK","year":"2022","unstructured":"Lv YK, Zhang HQ, Zhang J. Research progress of anti-\u03b3-aminobutyric acid B receptor encephalitis and a case report of paraneoplastic associated encephalitis and treatment analysis. Ibrain. 2022, 8:15-22. 10.1002\/ibra.12017","journal-title":"Ibrain"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"Titulaer MJ","year":"2011","unstructured":"Titulaer MJ, Soffietti R, Dalmau J, et al.. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011, 18:19-e3. 10.1111\/j.1468-1331.2010.03220.x","journal-title":"Eur J Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S289942","article-title":"A retrospective study of patients with GABA(B)R encephalitis: therapy, disease activity and prognostic factors","volume":"17","author":"Wen X","year":"2021","unstructured":"Wen X, Wang B, Wang C, Han C, Guo S. A retrospective study of patients with GABA(B)R encephalitis: therapy, disease activity and prognostic factors. Neuropsychiatr Dis Treat. 2021, 17:99-110. 10.2147\/NDT.S289942","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/295780-anti-gamma-aminobutyric-acid-b-gaba-b-receptor-encephalitis-a-case-series-analyzing-treatment-modalities-and-cancer-screening-recommendations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T18:52:32Z","timestamp":1755456752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/295780-anti-gamma-aminobutyric-acid-b-gaba-b-receptor-encephalitis-a-case-series-analyzing-treatment-modalities-and-cancer-screening-recommendations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.90318","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,17]]}}}